Asthma
The Asthma pipeline: 78 tracked drugs, 33 approved for this indication.
33 approved / phase 413 Phase 33 Phase 2/317 Phase 29 Phase 13 preclinical / unstaged
Compare the share prices of listed companies in Asthma →
Total attributable cost
$107.9B
$4,333/patient
Drug spend
Not yet sourced
All severities, current asthma (2021 estimate) · US
The Asthma pipeline
Key trial results for every approved and late-stage drug: Asthma results by drug.